Lifeworks Advisors LLC Has $6.34 Million Stock Holdings in The Clorox Company $CLX

Lifeworks Advisors LLC grew its stake in shares of The Clorox Company (NYSE:CLX) by 13.9% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 61,215 shares of the company’s stock after acquiring an additional 7,485 shares during the quarter. Lifeworks Advisors LLC owned about 0.05% of Clorox worth $6,344,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of CLX. Vermillion & White Wealth Management Group LLC bought a new stake in Clorox during the third quarter worth about $25,000. Caitlin John LLC grew its stake in Clorox by 1,807.1% during the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after buying an additional 253 shares in the last quarter. Darwin Wealth Management LLC bought a new position in Clorox in the 2nd quarter valued at about $29,000. Vision Financial Markets LLC increased its holdings in Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after buying an additional 200 shares during the period. Finally, Root Financial Partners LLC raised its position in shares of Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after buying an additional 145 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Morgan Stanley cut their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, April 13th. UBS Group lowered their price objective on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. Wells Fargo & Company cut their target price on Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research note on Monday, May 18th. Finally, Citigroup reduced their target price on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus target price of $103.40.

Clorox Stock Performance

Shares of Clorox stock opened at $96.57 on Monday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03. The stock has a market cap of $11.68 billion, a price-to-earnings ratio of 15.68, a P/E/G ratio of 0.46 and a beta of 0.54. The company’s fifty day moving average is $94.10 and its 200 day moving average is $104.11.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.Clorox’s quarterly revenue was up .1% on a year-over-year basis. During the same period in the prior year, the business posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts forecast that The Clorox Company will post 5.53 EPS for the current year.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of the stock in a transaction dated Tuesday, May 5th. The stock was bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.63% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.